BOOK A DEMO

Visit Us at the Digital International Liver CongressTM

Sonic Incytes is proudly presenting at the EASL Digital International Liver CongressTM, August 27-29, 2020. Visit our booth and read our Poster #FRI050 for a sneak preview of our upcoming product release: VelacurTM, a breakthrough, point of care ultrasound solution for assessing and managing chronic liver disease—an emerging global health epidemic, affecting one in four persons worldwide.

We recognize that healthcare practitioners need a better tool to routinely assess and manage those with identified risk factors for liver disease. VelacurTM is the first handheld 3D liver health assessment tool that is fast, accurate and portable. It provides a clear picture of the liver in real time, so you can be confident in your diagnosis, treatment and care.

Interested to find out more? Contact us at info@www.sonicincytes.com.

Sync up

with Sonic

Be in-the-know on all our latest news!

Subscribe to our e-newsletter.

Julia PinterMarketing Director

Julia Pinter brings over a decade of medical technology marketing experience spanning product commercialization, launch strategy, and sales enablement. Prior to joining Sonic Incytes, she served as Director of Global GI Product Marketing at PENTAX Medical, where she led global downstream marketing for the company’s largest portfolio — driving commercial launches of next-generation endoscopes, imaging systems, and AI platforms across the Americas, Europe, and Asia-Pacific. At Sonic Incytes, Julia leads downstream marketing initiatives to expand awareness and accelerate adoption of Velacur One®, translating its clinical and economic value into programs that support broader adoption of non-invasive liver assessment.